Pathologic specimens, both biopsies and endoscopic mucosal resections, for Barrett esophagus and Barrett-associated dysplasia and malignancy are common for pathologists in North America, and the incidence in South Asian countries seems to be increasing. Dysplasia and malignancy arising in intestinalized gastric-type mucosa raises issues in the interpretation of dysplasia and the evaluation of the depth of invasion of malignancies that are not seen in squamous dysplasia and squamous cell carcinoma. We review the North American approach to these lesions.

Citations

Citations to this article as recorded by  

• Complete circumferential endoscopic submucosal dissection for early Barrett’s neoplasia
  Douglas Motomura, Robert Bechara
  Gastrointestinal Endoscopy.2024; 99(3): 337.     CrossRef
• Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression
  Ksenia S. Maslyonkina, Alexandra K. Konyukova, Darya Y. Alexeeva, Mikhail Y. Sinelnikov, Liudmila M. Mikhaleva
  Cancer Medicine.2022; 11(2): 447.     CrossRef
• Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance
  Hanan M. Garalla, Nantaporn Lertkowit, Laszlo Tiszlavicz, Zita Reisz, Chris Holmberg, Rob Beynon, Deborah Simpson, Akos Varga, Jothi Dinesh Kumar, Steven Dodd, David Mark Pritchard, Andrew R. Moore, András I. Rosztóczy, Tibor Wittman, Alec Simpson, Graham
  Physiological Reports.2018; 6(10): e13683.     CrossRef
• A Comparison Study of Esophageal Findings on 18F-FDG PET/CT and Esophagogastroduodenoscopy
  KwanHyeong Jo, Soyoung Kim, Jongtae Cha, Sang Hyun Hwang, Narae Lee, Mijin Yun, Won Jun Kang
  Nuclear Medicine and Molecular Imaging.2016; 50(2): 123.     CrossRef